Andere Sprachen Natera, Inc.

Aktien

A14VPJ

US6323071042

NTRA

Gesundheitspflege Einrichtungen

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 10.02.2026			% 5 Tage	Veränd. 1. Jan.
211.65 ^USD	+0.51%		-7.04%	-7.61%

06.02.	Natera, Inc. startet EDEN-Studie zur frühzeitigen Risikobewertung von Präeklampsie und ungünstigen Schwangerschaftsausgängen	CI
02.02.	Natera reicht Antrag auf vorgezogene Marktzulassung für Test auf molekulare Resterkrankung Signatera CDx ein	MT

Andere Sprachen

06.02.	Natera, Inc. Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
06.02.	Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
02.02.	Natera Submits Premarket Approval Application for Molecular Residual Disease Test Signatera CDx
02.02.	Natera submits Signatera(TM) CDx PMA to FDA
02.02.	Natera Submits Signatera™ CDx PMA to FDA
02.02.	Natera, Inc. Submits Signatera CDx PMA to FDA
28.01.	Natera Completes Enrollment in Trial of Potential Non-Invasive Heart Rejection Test
28.01.	Natera Announces Completion of Enrollment in Randomized ACES-EMBTrial in Heart Transplantation
28.01.	Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation
26.01.	Prospera™ Featured in Landmark Interventional Study Advancing Lung Transplant Care
21.01.	Natera's Fetal Focus Single Gene NIPT Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine Meeting
21.01.	Natera, Inc. Publishes Clinical Validation of Latitude?? Tissue-Free MRD Test in Colorectal Cancer
21.01.	Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer
20.01.	Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting
14.01.	Natera : 44th Annual J.P. Morgan Healthcare Conference Presentation
14.01.	Natera : 44th Annual J.P. Morgan Healthcare Conference
13.01.	Natera Unveils AI Model to Enhance Cancer Recurrence Risk Assessment
13.01.	Natera, Inc. Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling
13.01.	Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling
12.01.	Natera, Inc. to Scale AI Foundation Models in Precision Medicine with NVIDIA
12.01.	Natera to scale AI Foundation Models in precision medicine with Nvidia
12.01.	Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
12.01.	Sector Update: Health Care Stocks Lower Pre-Bell Monday
12.01.	Independence, Under Review
12.01.	Natera Q4 Preliminary Revenue Rises; Shares Up Pre-Bell

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Natera, Inc.

Aktien

A14VPJ

US6323071042

NTRA

Gesundheitspflege Einrichtungen

Andere Sprachen

Filter